GANX
Gain TherapeuticsยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
GANX Profile
Gain Therapeutics, Inc.
A biotech company that develops novel allosteric binding sites and creating small molecule treatments
Biological Technology
06/26/2020
03/18/2021
NASDAQ Stock Exchange
23
12-31
Common stock
4800 Montgomery Lane, Suite 220 Bethesda, Maryland 20814
--
Gain Therapeutics, Inc., was incorporated in Delaware on June 26, 2020. The Company is a biotechnology company that develops novel small molecule therapies for the treatment of diseases in multiple therapeutic areas, including central nervous system (" CNS ") diseases, lysosomal storage disorders (" LSD "), metabolic disorders, and other diseases that can be targeted by protein degradation, such as oncology.
